Nonetheless, FDA concludes “the safety profile of the monovalent mRNA vaccines remains
favorable for use in young children”.
- FDA Admits COVID Vaccine Leads to ‘Significiantly Elevated’ Risk of Seizure in Toddlers www.thegatewaypundit.com/2024/03/fda-admits-covid-vaccine-leads-significiantly-elevated-risk
- Evaluation of Febrile Seizure Risk Following Ancestral Monovalent COVID19 mRNA Vaccination Among U.S. Children Aged 2-5 Years www.medrxiv.org/content/10.1101/2024.03.12.24304127v1.full.pdf
